Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) FCF Margin (2022 - 2025)

HCW Biologics (HCWB) has disclosed FCF Margin for 4 consecutive years, with 20759.54% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, FCF Margin fell 1965124.0% year-over-year to 20759.54%, compared with a TTM value of 2659.05% through Sep 2025, down 204964.0%, and an annual FY2024 reading of 564.48%, up 44603.0% over the prior year.
  • FCF Margin was 20759.54% for Q3 2025 at HCW Biologics, up from 50111.5% in the prior quarter.
  • Across five years, FCF Margin topped out at 478.34% in Q4 2022 and bottomed at 69375.24% in Q1 2025.
  • Average FCF Margin over 4 years is 10404.74%, with a median of 692.15% recorded in 2022.
  • The sharpest move saw FCF Margin skyrocketed 907244bps in 2024, then tumbled -6904387bps in 2025.
  • Year by year, FCF Margin stood at 478.34% in 2022, then plummeted by -226bps to 604.35% in 2023, then soared by 50bps to 300.35% in 2024, then tumbled by -6812bps to 20759.54% in 2025.
  • Business Quant data shows FCF Margin for HCWB at 20759.54% in Q3 2025, 50111.5% in Q2 2025, and 69375.24% in Q1 2025.